CompletedNot Applicable

Construction and Preliminary Application of Evidence-Based Nursing Protocol for Oral Mucositis Related to Tumor Therapy

China54 participantsStarted 2023-10-01

Plain-language summary

Describe the incidence and influencing factors of cancer therapy-related oral mucositis. Based on evidence-based practice, develop a standardized nursing protocol for cancer therapy-related oral mucositis that aligns with China's national context and demonstrates strong clinical feasibility, and establish a clinical management pathway for cancer therapy-related oral mucositis. Validate the implementability of the standardized nursing protocol, and evaluate its clinical effectiveness and cost-effectiveness.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a confirmed cancer diagnosis who are aware of their condition. * Patients currently undergoing non-surgical treatments such as chemotherapy, radiotherapy, immunotherapy, or targeted therapy. * Patients who voluntarily agree to participate in this study and provide informed consent. Exclusion Criteria: * Patients with autoimmune diseases; * Patients with primary or metastatic oral or lip cancer.; * Patients who are participating in other intervention studies.; * Swallowing problems existed in patients with Kubota drinking test \> level 3; * Coma or inability to open mouth, difficulty cooperating with the researcher.

What they're measuring

Incidence of oral mucositis

Timeframe: One treatment cycle (21days)

Trial details

NCT IDNCT07305766

SponsorPeking Union Medical College

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-01

View on ClinicalTrials.gov More Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy trials